MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative

    Z. Meyer, C. Marras, A. Naito, N. Dahodwala, A. Ramirez-Zamora, M. Rose Rafferty, M. Neault, J. Beck, R. Deleon, T. Davis, S. Mantri, K. Mills, J. Miyasaki, E. Nelson, A. Brown, D. Weintraub, A. Allen (Miami, USA)

    Objective: Assess the feasibility of systematic depression screening of people with Parkinson’s (PWP) and determine barriers in the specialist movement disorders setting. Background: While depression…
  • 2022 International Congress

    Leading Therapeutic Molecules Target Transcription Factors Binding to Repressor Region in FXN Gene

    V. Swarup, H. Singh, D. Gupta, I. Singh, A. Srivastava (New Delhi, India)

    Objective: To investigate interactions of transcription factors (TFs) binding to repressor region located upstream to FXN gene with leading therapeutic molecules. Background: Low levels of…
  • 2022 International Congress

    Specificity of neuronal activity in globus pallidus in patients with DYT1 dystonia

    I. Dzhalagoniya, S. Usova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: The aim of this study was a comparative analysis of the neuronal activity of globus pallidus in patients with DYT1 dystonia and idiopathic dystonia.…
  • 2022 International Congress

    Initial experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson’s disease in Slovenia

    E. Pipan, N. Zupančič Križnar, L. Ocepek, R. Rajnar, M. Kramberger, M. Menih, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To study the initial experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) in routine clinical practice at two University Medical Centers in Slovenia. Background: The…
  • 2022 International Congress

    Meta-analysis between LARGE-PD cohorts reveals new potential susceptibility regions on the chromosome X

    T. Peixoto Leal, S. Rao, M. Inca-Martinez, M. Gouveia, J. French-Kwawu, V. Borda, E. Mason, D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Sarapura-Castro, A. Rivera-Valdivia, A. Medina, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, S. Moreno, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Cleveland, USA)

    Objective: Perform Chromosome X-Wide Association Study (XWAS) per country from The Latin American Research Consortium on the Genetics of PD (LARGE-PD) and meta-analyze the results…
  • 2022 International Congress

    Montreal Cognitive Assessment cutoff point for cognitive impairment in Mexican subjects with PD: A neuropsychological approach

    AJ. Hernández-Medrano, GI. Cerda-Hernández, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, G. Sánchez-Dinorín, E. Lobato-Ildefonso, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)

    Objective: To determine an optimal cutoff point of the MoCA for cognitive impairment detection in Mexican persons with PD. Background: Cognitive impairment (CI) is frequent…
  • 2022 International Congress

    Study of age related neurodegeneration of Cerebellum Basal Ganglia direct subcortical white matter tracts using fixel-based analysis.

    V. Radhakrishnan, C. Gallea, C. Kesavadas, B. Thomas, S. Krishnan, A. Kishore (Trivandrum, India)

    Objective: The goal of the study is to use diffusion weighted imaging to confirm and expand on findings of structural tracks linking cerebellum (CB) and…
  • 2022 International Congress

    “Belly Dance Tremor” – Hip and Truncal tremor in Parkinson’s disease

    S. Mittal, T. Maiti (Abu Dhabi, United Arab Emirates)

    Objective: To report unusual presentation of Young-Onset Parkinson’s disease with disabling hip and trunk rest tremor resembling “belly dance”. Background: Proximal tremor is not commonly…
  • 2022 International Congress

    AN ATYPICAL ONSET OF PRIMARY FAMILIAL BRAIN CALCIFICATION: A CASE REPORT.

    P. Santurelli, D. Ciprietti, T. Carrer, M. Carecchio (Padova, Italy)

    Objective: To describe a case of PFBC with atypical clinical onset. Background: Primary Familial Brain Calcification (PFBC), also known as Fahr's Disease, is a rare…
  • 2022 International Congress

    CerebNet: Deep learning cerebellar subsegmentation for fast and reliable atrophy quantification

    J. Faber, D. Kuegler, E. Bahrami, L. Heinz, D. Timmann, T. Ernst, K. Deike-Hofmann, B. Vande Warrenburg, G. Oz, J. van Gaalen, J. Joers, K. Reetz, T. Klockgether, M. Reuter (Bonn, Germany)

    Objective: Establish a fast and reliable automatic tool for cerebellar subsegmentation. Background: Quantifying the volume of the cerebellum and its lobes is of profound interest…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley